PitchBook News - What could go wrong from here?

Also: Is medtech innovation dead?; Agtech startups raising record sums of VC funding; Don't miss the new, live version of our VC Dealmaking Indicator!
Read online | Don't want to receive these emails? Manage your subscription.
Log in
The Research Pitch
December 11, 2021
We just launched a live version of our VC Dealmaking Indicator, which quantifies the relationship between startups and venture investors.

The Indicator leverages data from five different deal terms as well as the time between rounds, valuation step-ups, and percent of ownership acquired.

Check it out (and save it to your bookmarks!)
The US financial markets and PE industry are booming. What's next?
More than 18 months have passed since the world and financial markets were thrown into disarray as a result of the COVID-19 pandemic.

While life has still not fully returned to normal for most, in many ways, financial assets and economies have not only recovered but boomed in recent quarters.

While the party is going full swing right now, the cautious observer might ask: What could go wrong from here?

From a long-term perspective, we see a challenging period ahead for institutional investors as rising valuations across asset classes have further pushed down expected returns.

Recent forecasts suggest only PE and emerging market equity will return over the average US pension's target of 7% per annum over the next 10 years.

We believe this will motivate asset allocators to increase risk in portfolios by pushing further into alternatives, including PE, and directly adding leverage.

There are several short-term risks to the outlook that deserve attention, as well.

Rising inflation to its highest rate in 30 years and a tight labor market suggest we are late in the economic cycle, to which the Federal Reserve has responded by signaling the beginning of tighter monetary policy.

Historically, this has been a poor environment for risk assets as discount rates increase and real growth slows.
Data is seasonally adjusted and contains estimates for the four most recent quarters.

Meanwhile, over the past two quarters, PE deals and exits have been completed at their highest levels relative to trends in at least the last 20 years.

Although the current torrid pace is unsustainable, near-record-high dry powder and corporate cash balances and a red-hot IPO market—as well as an ample and cheap supply of debt financing—highlight a supportive backdrop for completing PE deals and exits.

For more analysis on what's next for financial markets and PE, click to download our free Quantitative Perspectives report: US PE: Recovery and Beyond

Please feel free to reach out with any feedback or questions.

Andrew Akers, CFA
Quantitative Research Analyst
Share:   Email    LinkedIn    Twitter    Facebook
Thematic Research
Taking the Pulse of Medtech Innovation

Is medtech innovation dead?

Our analysts recently examined the VC funding gap within life sciences—exploring why biotech has overshadowed medtech (by a 3:1 basis in recent years), as well as what medtech's future holds.
Medtech's proportion of VC raised YTD is at an all-time low.

Innate differences in average time to market, the FDA regulatory approval process, average associated costs, clinical trial requirements, and platform versatility are key factors that influence life sciences investors' decisions when investing in medtech versus biotech:
read the free research
Emerging Tech Research
AGTECH: Venture funding for global agtech startups is absolutely flourishing.

The sector collectively raised $3.2 billion in Q3, setting what's by far an all-time record and driving annual deal value to $7.8 billion—already surpassing 2020's full-year total by more than 20%.

In our latest agtech research, we dive deeper into the data and also break down new emerging opportunities:
  • New biochemicals aim to reduce reliance on synthetic chemicals.

  • Soil measurement tools play a critical role in restoring soil health.
read an executive summary
In the News
Our insights and data featured in the press:
  • Why autonomous middle- and last-mile startups like Gatik, Nuro and TuSimple could eclipse robotaxi leaders Waymo and Cruise in commercializing at scale. [Reuters]

  • "The idea that 'every company will be a fintech company' a few years ago can now be rearticulated as 'every company will be a crypto company.'" [Quartz]

  • PE dealmaking is on pace to set massive new records this year. "If there is a headline for next year, it would probably be, 'the bigs keep getting bigger.'" [PE Hub]

  • Who's pouring money into supply chain tech? [WSJ]

  • In the last six months, private equity firms have been exiting companies at a higher rate than they have in at least 20 years. [Fortune]
If you're a journalist interested in interviewing our analysts or requesting data, contact our PR team.
Highlights from our other recent research:

Market updates Thematic research Emerging Technology Research Coming next week (subject to change)
  • US PE Middle Market Report
  • ETR: Fintech
  • ETR: Retail Healthtech (sneak peek)
  • US Private Equity Outlook for 2022
  • European Private Capital Outlook for 2022
  • PitchBook's Fundraising Guide for GPs
  • Archetypal Investing in Climate Tech
  • VC in Southern Europe (sneak peek)
Thanks for reading! Feel free to email us any time with feedback, questions or tips!

Learn more about the PitchBook Institutional Research Group, meet our analysts, or access our full research libraries for clients and non-clients.

Were you forwarded this newsletter? Sign up at pitchbook.com/subscribe.
Since yesterday, the PitchBook Platform added:
VC valuations
See what our data software can do
About PitchBook | Terms of use | Advertise with us | Contact

Follow us:   in   twtr   fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

© 2021 PitchBook Data. All rights reserved.
Venture capital, private equity and M&A financial information technology provider.

Key phrases

Older messages

A checkup on medtech innovation

Friday, December 10, 2021

How VC-backed IPOs stack up; CloudBees lands on $245M; Databricks unveils new venture fund; tunneling robot startup scoops up $30M Read online | Don't want to receive these emails? Manage your

Agtech startups reap record VC funding

Thursday, December 9, 2021

Nubank raises $2.6B in biggest LatAm IPO; HashiCorp goes public at $16B; Claroty snags $400M; SoftBank backs mental health startup Read online | Don't want to receive these emails? Manage your

VC valuation trends in seven charts

Wednesday, December 8, 2021

Six notable VC deals from 2021; Ursa Major lands $85M for rocket tech; Felix Capital brings on former Meta exec; Greycroft targets $1B+ fund Read online | Don't want to receive these emails? Manage

PE's recovery—and beyond

Tuesday, December 7, 2021

SEC's SPAC scrutiny ensnares marquee deals; Genesys lands $580M; Bain Capital Ventures taps Christina Melas-Kyriazi; Africa's TradeDepot raises $110M Read online | Don't want to receive

Parent-tech investments on the rise

Monday, December 6, 2021

What's driving AI & ML mega-exits; Didi's planned delisting sends ripples; LingoAce lands $160M; SoftBank leads $50M round for Clarity AI Read online | Don't want to receive these

Consumer prices reach 30 year high

Thursday, January 20, 2022

.... and Peloton considers drastic turnaround plan View this email in your browser 20th January 2022 Bite-sized business news from the UK and beyond Good morning Yesterday 102 millionaires and

Planes are grounded

Thursday, January 20, 2022

Good morning! BharatPe doesn't have it Better. The fintech company's MD and co-founder Ashneer Grover, who is also a judge on Shark Tank India, has taken a “voluntary leave of absence”

Jan. 19 - Escada America files Ch. 11 | Forever 21 names new CEO

Wednesday, January 19, 2022

Women's fashion retailer Escada America files for bankruptcy; Forever 21 turns to retail veteran Winnie Park as CEO; Are Sephora and Ulta on a collision course?; Walmart signals metaverse plans

Assessing PE mega-fund growth

Wednesday, January 19, 2022

A new look at fund performance; Microsoft scores Activision Blizzard for $68.7B; Curbio brings home $65M; Mythical Games lands Polystream Read online | Don't want to receive these emails? Manage

Big News: I Just Sold the Niche Site Project 4 Site!

Wednesday, January 19, 2022

I have BIG news to share today! I've officially sold my site, OwnTheYard.com! This has been my public case study site for Niche Site Project 4 over the past 3 years. You can read all the news about

Jan 19: BetMGM CEO: market getting smarter

Wednesday, January 19, 2022

BetMGM FY21 update, Full House Q4 preliminary results, Esports Technologies earnings guidance, Michigan Dec21, NeoGames/Aspire reaction. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Posting better LinkedIn content...

Wednesday, January 19, 2022

Curious about NFTs, Reader? If you're ready to discover how to use Web 3.0 to grow your business, we've just launched a new show all about this exciting new frontier. Simply search “Crypto

Jan. 19 - Anheuser-Busch refreshes logo | Oscar Mayer's 'bologna-inspired' face mask

Wednesday, January 19, 2022

Oscar Mayer's 'bologna-inspired' face masks poke fun at self-care; As events again go virtual, marketing takeaways from a timely metaverse activation; TV tops in video for reaching

Digital Marketing in 2022: KPIs & Metrics That Matter

Wednesday, January 19, 2022

Learn how to set effective, data-backed KPIs and metrics to accurately assess your strategies. Learn how to set effective, data-backed KPIs and metrics to accurately assess your strategies. What: KPIs

How to Use Instagram Insights (in 9 Easy Steps)

Wednesday, January 19, 2022

If you're using Instagram in your role, it's critical to analyze your performance to make better marketing decisions on the platform. HubSpot Marketing Blog Jan. 19, 2022 marketer reviews